Role of vasoactive intestinal polypeptide (VIP) in regulating the pituitary function in man
- 1 March 1984
- Vol. 5 (2) , 389-394
- https://doi.org/10.1016/0196-9781(84)90240-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27Nature, 1983
- Serotonin stimulates vasoactive intestinal polypeptide release from rat hypothalamus in vitroBrain Research, 1983
- VIP STIMULATES PROLACTIN RELEASE IN WOMENThe Lancet, 1981
- The influence of vasoactive intestinal polypeptide and cholecystokinin of prolactin release in rat and human monolayer culturesLife Sciences, 1981
- Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomasFEBS Letters, 1980
- Effect of vasoactive intestinal polypertide on prolactin release in vitroLife Sciences, 1979
- Vasoactive intestinal polypeptide: Release into hypophyseal portal bloodLife Sciences, 1979
- Vasoactive intestinal polypeptide (VIP) in human cerebrospinal fluidBrain Research, 1977
- Vasoactive Intestinal Polypeptide: Abundant Immunoreactivity in Neural Cell Lines and Normal Nervous TissueScience, 1976
- Effect of hypothalamic surgery on prolactin release induced by 5-hydroxytryptophan (5-HTP) in rats.Endocrinologia Japonica, 1976